As 2024 ushers in political change, one of the most contentious issues bubbling beneath the surface is public health — notably, the role of addictive substances ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

AstraZeneca’s growth was driven by its portfolio of products in the oncology, biopharmaceuticals and rare disease segments ...

To build out the facility and ensure the success of this new venture, QPS has hired Tia Hexom, PhD, (Senior Director of Cell ...

Sanjay Kapote, President of Aptar Pharma India and Southeast Asia said, in the last 10 years, the company had achieved ...

Esperion Therapeutics' aggressive commercialization efforts have significantly boosted retail prescriptions and broadened ...

Onyx Biotec is launching an SME IPO to raise Rs 29 crore by offering shares at Rs 58-61 apiece. The pharmaceutical company ...

“Compounded products claiming to contain semaglutide have not undergone verification nor evaluation by Sahpra to assess ...

Journey Medical Corporation (Nasdaq: DERM) ("Journey Medical” or "the Company”, "we”, or "our”), a commercial-stage ...

Vice President of Shanghai Pharmaceuticals Li Dongming said on Tuesday that he hopes there will be more investment from ...

They emphasised the need for collaboration between pharmaceutical manufacturers and the government to increase domestic ...